CG Oncology - CGON Operating profit EBITDA

Brandmark of cgoncology.com (CGON)

By attracting leading oncologists through advanced laboratories, CG Oncology, Inc. (CGON) is developing the potential for clinical breakthroughs. The consolidated EBITDA reflects capital inflow dynamics, where the value 0.00 serves as a baseline indicator of current strength. Fundamentally, the business relies on contract manufacturing of drugs and delegates the conduct of research to external vendors, while maintaining strict quality control over all stages of therapy.

CGON - CG Oncology Operating profit EBITDA over the range 11/23/2025 - 11/16/2026

CG Oncology Inc (CGON) - metric breakdowns and financial figures

- current quotes and average value forecast:
Fundamental company valuation:cgoncology.com
Mass-produced product of CG Oncology

This indicator captures the maturity stage of business processes by measuring net cash flow from operating activities before deducting depreciation and interest. By analyzing the projected EBITDA level, an investor assesses the ability of CG Oncology, Inc. (CGON) to generate sustainable income, which, in the case of certified bladder cancer therapy, confirms the company's transition to a multi-year phase of commercial profit extraction through clinics.

Competitors of CG Oncology, Inc. (CGON)

Operating profit EBITDA beigene.com ONC|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage (AAPG) - Profit before payment of interest, taxes and amortization|UroGen - Income before deduction of interest, taxes and amortization|BCAX (Bicara Therapeutics Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization personalis.com PSNL|Operating profit EBITDA ERAS|Delcath Systems - Operating profit before amortization|Y-mAbs Therapeutics Inc - Operating profit before deduction of amortization|Operating profit EBITDA Aura Corp AURA|CADL - Profit before payment of interest, taxes and amortization|Accuray (ARAY) - Operating profit before deduction of amortization|SLS: Operating profit EBITDA|Actuate Therapeutics (ACTU) - Operating profit EBITDA|Operating profit before deduction of amortization CTOR|HURA: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Protara Therapeutics (TARA)|Company profit before taxes, interest and amortization FATE|Operating profit EBITDA WHWK (aadibio.com)|Company profit before taxes, interest and amortization TCRX (TScan)|CSBR - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization XBIT (XBiotech Inc)|cel-sci.com (CVM) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization OSTX (OS Therapies Incorporated)|Profit before payment of interest, taxes and amortization Radiopharm Theranostics Ltd|Profit before interest, taxes and amortization Artiva Biotherapeutics ARTV|Operating profit EBITDA ANL|VERU - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Tempest Therapeutics TPST|xiliotx.com (XLO) - Profit before interest, taxes and amortization|RENB: Operating profit before deduction of amortization|Operating profit before depreciation charges Mural Oncology PLC (MURA)|KAPA (Kairos Pharma Inc) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization OnKure Therapeutics Inc (OKUR)|GDTC (CytoMed Therapeutics Ltd) - Operating profit EBITDA|Operating profit before deduction of amortization Curis, Inc. (CRIS)|Operating profit EBITDA APLM|Company profit before taxes, interest and amortization THAR|Operating profit EBITDA ADVB (advanbiomed.com)|GNPX - Operating profit before deduction of amortization|CLDI: Operating profit before deduction of amortization|SBFM - Operating profit EBITDA|Xenetic Biosciences (XBIO) - Profit before payment of interest, taxes and amortization|SLRX: Company profit before taxes, interest and amortization|PPBT (Purple Biotech Ltd) - Operating profit EBITDA|Profit before interest, taxes and amortization American Oncology Network, Inc. AONC|Operating profit EBITDA BGNE|Operating income before deduction of amortization Checkpoint Therapeutics|Elevation Oncology, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA iCAD, Inc. ICAD|Ikena Oncology, Inc. - Operating profit EBITDA|NTBL - Operating profit EBITDA|VIRX (Viracta Therapeutics) - Operating profit before deduction of amortization|MorphoSys AG - Income before deduction of interest, taxes and amortization|NAYA (NAYA Biosciences Corp) - Operating profit EBITDA|Operating profit EBITDA Ascentage Pharma Group International